At IAS 2018, Adam Cheifetz, MD, discussed the use of therapeutic drug concentration monitoring and weighed the benefits of this approach in treating inflammatory bowel disease.
At IAS 2018, Adam Cheifetz, MD, discussed the use of therapeutic drug concentration monitoring and weighed the benefits of this approach in treating inflammatory bowel disease.
At IAS 2018, Adam Cheifetz, MD,...